CD44 expression is related to poor prognosis of hypopharyngeal squamous cell carcinoma

Acta Oto-Laryngologica

Volumn 131, Issue 3, 2011, Pages 323-329

  Uwa, Nobuhiro ^a   Kataoka, Tatsuki R ^a   Torii, Ikuko ^a   Sato, Ayuko ^a   Nishigami, Takashi ^a   Song, Misa ^a   Daimon, Takashi ^a   Saeki, Nobuo ^a   Sagawa, Kousuke ^a   Mouri, Takeshi ^a   Terada, Tomonori ^a   Sakagami, Masafumi ^a   Tsujimura, Tohru ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

disease free survival; distant metastasis; Immunohistochemistry; marker; progression; TNM

Indexed keywords

DOCETAXEL; HERMES ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY; TUMOR CELL;

ADULT; AGED; ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE;

EID: 79951649402     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.3109/00016489.2010.528792     Document Type: Article

References (20)

1. Buckley JG, MacLennan K. Cervical node metastases in laryngeal and hypopharyngeal cancer: a prospective analysis of prevalence and distribution. Head Neck 2000;22:380-5. (Pubitemid 30413304)
2. Fujii T, Sato T, Yoshino K, Uemura H, Kurita T, Terada T. Prognostic factor for hypopharyngeal cancer: a univariate and multivariate study of 142 cases. Head Neck Cancer 2000;26: 489-96.
3. Spector GJ. Distant metastases from laryngeal and hypopharyngeal cancer. ORL J Otorhinolaryngol Relat Spec 2001;63: 224-8. (Pubitemid 32620174)
4. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol 1993;54:271-335. (Pubitemid 23289255)
5. Bourguignon LY, Gilad E, Brightman A, Diedrich F, Singleton P. Hyaluronan-CD44 interaction with leukemiaassociated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells. J Biol Chem 2006;281: 14026-40. (Pubitemid 43848329)
6. Wang SJ, Bourguignon LY. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer. Arch Otolaryngol Head Neck Surg 2006; 132:771-8. (Pubitemid 44086442)
7. Sobin LH, Gospodarowicz MK, Wittekind C. 2009. TNM classification of malignant tumors. Hoboken, NJ: Wiley-Blackwell.
8. Nishigami T, Onodera M, Torii I, Sato A, Tao LH, Kushima R, et al. Comparison between mucinous cystic neoplasm and intraductal papillary mucinous neoplasm of the branch duct type of the pancreas with respect to expression of CD10 and cytokeratin 20. Pancreas 2009;38: 558-64.
9. Fox SB, Fawcett J, Jackson DG, Collins I, Gatter KC, Harris AL, et al. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 1994;54:4539-46. (Pubitemid 24273174)
10. Yu Q, Toole BP, Stamenkovic I. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J Exp Med 1997;186: 1985-96. (Pubitemid 28013682)
11. Yu Q, Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 1999;13: 35-48. (Pubitemid 29045114)
12. Wong RJ. Current status of FDG-PET for head and neck cancer. J Surg Oncol 2008;97:649-52. (Pubitemid 351812964)
13. Wang SJ, Wong G, de Heer AM, Xia W, Bourguignon LY. CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope 2009;119: 1518-30.
14. Répássy G, Forster-Horváth C, Juhász A, Adány R, Tamássy A, Tímár J. Expression of invasion markers CD44v6/v3, NM23 and MMP2 in laryngeal and hypopharyngeal carcinoma. Pathol Oncol Res 1998;4: 14-21. (Pubitemid 28257191)
15. Hofmann M, Rudy W, Zöller M, Tölg C, Ponta H, Herrlich P, et al. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 1991;51: 5292-7.
16. Kunishi M, Kayada Y, Yoshiga K. Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph nodemetastasis. Int J Oral Maxillofac Surg 1997;26: 280-3. (Pubitemid 127357796)
17. Kanke M, Fujii M, Kameyama K, Kanzaki J, Tokumaru Y, Imanishi Y, et al. Clinicopathological significance of expression of CD44 variants in head and neck squamous cell carcinoma. Jpn J Cancer Res 2000;91: 410-15. (Pubitemid 30312693)
18. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005;5:275-84. (Pubitemid 40488633)
19. Prince ME, Ailles LE. Cancer stem cells in head and neck squamous cell cancer. J Clin Oncol 2008;26: 2871-5.
20. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007;104:973-8. (Pubitemid 46154721)